These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37181352)
1. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Fairweather D; Bruno KA; Darakjian AA; Bruce BK; Gehin JM; Kotha A; Jain A; Peng Z; Hodge DO; Rozen TD; Munipalli B; Rivera FA; Malavet PA; Knight DRT Front Med (Lausanne); 2023; 10():1096180. PubMed ID: 37181352 [TBL] [Abstract][Full Text] [Related]
2. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome. Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of ADHD and Autism Spectrum Disorder in Children with Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome: A Retrospective Study. Kindgren E; QuiƱones Perez A; Knez R Neuropsychiatr Dis Treat; 2021; 17():379-388. PubMed ID: 33603376 [TBL] [Abstract][Full Text] [Related]
4. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States. Estrella E; Frazier PA Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820 [TBL] [Abstract][Full Text] [Related]
5. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory. Bennett SE; Walsh N; Moss T; Palmer S Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520 [TBL] [Abstract][Full Text] [Related]
6. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome. DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116 [TBL] [Abstract][Full Text] [Related]
7. An online pain management program for people with hypermobile Ehlers-Danlos Syndrome or hypermobility spectrum disorder: a three-staged development process. Chew MT; Ilhan E; Nicholson LL; Kobayashi S; Chan C Disabil Rehabil; 2024 May; ():1-11. PubMed ID: 38738812 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of MTHFR Polymorphisms in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobile Spectrum Disorders in a US Hypermobility Clinic. Courseault J; Umar M; Bordnick P; Simons J; Volic M; Stock A; Bix G ACR Open Rheumatol; 2024 Jul; 6(7):399-402. PubMed ID: 38523329 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey. Teran-Wodzinski P; Kumar A Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685 [TBL] [Abstract][Full Text] [Related]
10. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders. Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175 [TBL] [Abstract][Full Text] [Related]
11. Anorectal manometry for the diagnosis of pelvic floor disorders in patients with hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome. Zhou W; Zikos TA; Halawi H; Sheth VR; Gurland B; Nguyen LA; Neshatian L BMC Gastroenterol; 2022 Dec; 22(1):538. PubMed ID: 36564719 [TBL] [Abstract][Full Text] [Related]
12. Societal participation in ehlers-danlos syndromes and hypermobility spectrum disorder, compared to fibromyalgia and healthy controls. De Baets S; Cruyt E; Calders P; Dewandele I; Malfait F; Vanderstraeten G; Van Hove G; van De Velde D PLoS One; 2022; 17(6):e0269608. PubMed ID: 35709306 [TBL] [Abstract][Full Text] [Related]
13. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain. Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931 [TBL] [Abstract][Full Text] [Related]
14. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder. Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648 [TBL] [Abstract][Full Text] [Related]
15. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Chuchin JD; Ornstein TJ Disabil Rehabil; 2024 Sep; 46(18):4234-4245. PubMed ID: 37843031 [TBL] [Abstract][Full Text] [Related]
16. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome. Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794 [TBL] [Abstract][Full Text] [Related]